Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 8,253Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 1Alembic Pharmaceuticals Limited

02 1Amneal Pharmaceuticals

03 1Chartwell Pharmaceuticals llc

04 1Cipla

05 1Encube Ethicals

06 1Lupin Ltd

07 1Padagis

08 1Pfizer Inc

09 1Taro Pharmaceutical Industries

10 1Zydus Lifesciences

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

DCAT Week
Not Confirmed
arrow
arrow
DCAT Week
Not Confirmed

TAVABOROLE

Brand Name : TAVABOROLE

Dosage Form : SOLUTION;TOPICAL

Dosage Strength : 5%

Packaging :

Approval Date : 2020-10-21

Application Number : 212188

Regulatory Info : RX

Registration Country : USA

blank

02

ISPE Aseptic Conference
Not Confirmed
arrow
arrow
ISPE Aseptic Conference
Not Confirmed

TAVABOROLE

Brand Name : TAVABOROLE

Dosage Form : SOLUTION;TOPICAL

Dosage Strength : 5%

Packaging :

Approval Date : 2020-11-25

Application Number : 212256

Regulatory Info : RX

Registration Country : USA

blank

03

ISPE Aseptic Conference
Not Confirmed
arrow
arrow
ISPE Aseptic Conference
Not Confirmed

TAVABOROLE

Brand Name : TAVABOROLE

Dosage Form : SOLUTION;TOPICAL

Dosage Strength : 5%

Packaging :

Approval Date : 2021-02-03

Application Number : 211963

Regulatory Info : RX

Registration Country : USA

blank

04

ISPE Aseptic Conference
Not Confirmed
arrow
arrow
ISPE Aseptic Conference
Not Confirmed

TAVABOROLE

Brand Name : TAVABOROLE

Dosage Form : SOLUTION;TOPICAL

Dosage Strength : 5%

Packaging :

Approval Date : 2021-02-09

Application Number : 212224

Regulatory Info : RX

Registration Country : USA

blank

05

DCAT Week
Not Confirmed
arrow
arrow
DCAT Week
Not Confirmed

TAVABOROLE

Brand Name : TAVABOROLE

Dosage Form : SOLUTION;TOPICAL

Dosage Strength : 5%

Packaging :

Approval Date : 2020-10-13

Application Number : 211297

Regulatory Info : RX

Registration Country : USA

blank

06

ISPE Aseptic Conference
Not Confirmed
arrow
arrow
ISPE Aseptic Conference
Not Confirmed

TAVABOROLE

Brand Name : TAVABOROLE

Dosage Form : SOLUTION;TOPICAL

Dosage Strength : 5%

Packaging :

Approval Date : 2021-02-08

Application Number : 212168

Regulatory Info : RX

Registration Country : USA

blank

07

ISPE Aseptic Conference
Not Confirmed
arrow
arrow
ISPE Aseptic Conference
Not Confirmed

TAVABOROLE

Brand Name : TAVABOROLE

Dosage Form : SOLUTION;TOPICAL

Dosage Strength : 5%

Packaging :

Approval Date : 2020-10-13

Application Number : 211848

Regulatory Info : RX

Registration Country : USA

blank

08

ISPE Aseptic Conference
Not Confirmed
arrow
arrow
ISPE Aseptic Conference
Not Confirmed

TAVABOROLE

Brand Name : KERYDIN

Dosage Form : SOLUTION;TOPICAL

Dosage Strength : 5% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Packaging :

Approval Date : 2014-07-07

Application Number : 204427

Regulatory Info : DISCN

Registration Country : USA

blank

09

ISPE Aseptic Conference
Not Confirmed
arrow
arrow
ISPE Aseptic Conference
Not Confirmed

TAVABOROLE

Brand Name : TAVABOROLE

Dosage Form : SOLUTION;TOPICAL

Dosage Strength : 5%

Packaging :

Approval Date : 2021-05-07

Application Number : 212215

Regulatory Info : RX

Registration Country : USA

blank

10

ISPE Aseptic Conference
Not Confirmed
arrow
arrow
ISPE Aseptic Conference
Not Confirmed

TAVABOROLE

Brand Name : TAVABOROLE

Dosage Form : SOLUTION;TOPICAL

Dosage Strength : 5%

Packaging :

Approval Date : 2023-04-10

Application Number : 212294

Regulatory Info : RX

Registration Country : USA

blank